Despite seeing encouraging results, the New Brunswick woman says she doesn't qualify for a program that helps pay for food ...

BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.

WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

Erica spent years dealing with symptoms she didn’t realize were connected to polycystic ovarian syndrome until she was ...

Kate Martin, the former college teammate of Caitlin Clark turned WNBA guard, is having a solid 2025 season. The 6-foot, ...

The shares of this leading pharmaceutical company are in focus after the company secured the USFDA's approval for its key ...

BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription Rights") for the Company's existing shareholders at the time ...

Bergen, Norway and Oslo, Norway, 30 June 2025 - BerGenBio ASA (OSE: BGBIO) ("BerGenBio" or the "Company") and Oncoinvent ASA (OSE: ONCIN) ("Oncoinvent") announce that they have entered into a merger ...

Susanne Dolan Reney Taylor passed away peacefully in her home in Chatham, MA, after a long battle with ovarian cancer. She ...